Literature DB >> 19015836

Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats.

Leigh V Panlilio1, Carmen Mazzola, Julie Medalie, Britta Hahn, Zuzana Justinova, Filippo Drago, Jean Lud Cadet, Sevil Yasar, Steven R Goldberg.   

Abstract

RATIONALE: Endocannabinoids are involved in a variety of behavioral and physiological processes that are just beginning to be understood. In the five-choice serial reaction-time task, exogenous cannabinoids have been found to alter attention, but endocannabinoids such as anandamide have not been studied.
OBJECTIVES: We used this task to evaluate the effects of anandamide in rats. Since anandamide is a ligand for not only cannabinoid receptors but also transient receptor potential vanilloid 1 (TRPV1) receptors, and as recently suggested, peroxisome proliferator-activated nuclear receptor-alpha (PPARalpha), we also determined whether anandamide's effects in this task were mediated by each of these receptors.
MATERIALS AND METHODS: Whenever one of five holes was illuminated for 2 s, a food pellet was delivered if a response occurred in that hole during the light or within 2 s after the light.
RESULTS: Anandamide increased omission errors and decreased responding during inter-trial intervals. These effects were blocked by the TRPV1 antagonist capsazepine, but not by the cannabinoid-receptor antagonist rimonabant or the PPARalpha antagonist MK886. Testing with open-field activity and food-consumption procedures in the same rats suggested that the disruption of operant responding observed in the attention task was not due to motor depression, anxiety, decreased appetite, or an inability to find and consume food pellets.
CONCLUSIONS: The vanilloid-dependent behavioral disruption induced by anandamide was specific to the operant attention task. These effects of anandamide resemble effects of systemically administered dopamine antagonists and might reflect changes in vanilloid-mediated dopamine transmission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015836      PMCID: PMC2695254          DOI: 10.1007/s00213-008-1399-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task.

Authors:  T Koskinen; J Sirviö
Journal:  Brain Res Bull       Date:  2001-01-01       Impact factor: 4.077

Review 2.  Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine.

Authors:  John D Salamone; Mercè Correa
Journal:  Behav Brain Res       Date:  2002-12-02       Impact factor: 3.332

3.  Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances.

Authors:  S W Hwang; H Cho; J Kwak; S Y Lee; C J Kang; J Jung; S Cho; K H Min; Y G Suh; D Kim; U Oh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement.

Authors:  B Hahn; M Shoaib; I P Stolerman
Journal:  Behav Pharmacol       Date:  2002-12       Impact factor: 2.293

5.  Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.

Authors:  V Di Marzo; I Lastres-Becker; T Bisogno; L De Petrocellis; A Milone; J B Davis; J J Fernandez-Ruiz
Journal:  Eur J Pharmacol       Date:  2001-05-25       Impact factor: 4.432

Review 6.  The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2002-08-09       Impact factor: 4.530

Review 7.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.

Authors:  Laetitia Prut; Catherine Belzung
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

8.  Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.

Authors:  T Rubino; N Realini; C Castiglioni; C Guidali; D Viganó; E Marras; S Petrosino; G Perletti; M Maccarrone; V Di Marzo; D Parolaro
Journal:  Cereb Cortex       Date:  2007-10-05       Impact factor: 5.357

9.  Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions.

Authors:  Filippo Passetti; Liat Levita; Trevor W Robbins
Journal:  Behav Brain Res       Date:  2003-01-06       Impact factor: 3.332

Review 10.  Cannabinergic ligands.

Authors:  Sonya L Palmer; Ganesh A Thakur; Alexandros Makriyannis
Journal:  Chem Phys Lipids       Date:  2002-12-31       Impact factor: 3.329

View more
  11 in total

1.  Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis.

Authors:  Andras Garami; Eszter Pakai; Daniela L Oliveira; Alexandre A Steiner; Samuel P Wanner; M Camila Almeida; Vladimir A Lesnikov; Narender R Gavva; Andrej A Romanovsky
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

2.  Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.

Authors:  Jenny L Wiley; D Matthew Walentiny; Robert E Vann; Cassandra Y Baskfield
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors.

Authors:  Michael Z Leonard; Shakiru O Alapafuja; Lipin Ji; Vidyanand G Shukla; Yingpeng Liu; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman; Brian D Kangas
Journal:  J Pharmacol Exp Ther       Date:  2017-09-25       Impact factor: 4.030

4.  Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors.

Authors:  Carmen Mazzola; Julie Medalie; Maria Scherma; Leigh V Panlilio; Marcello Solinas; Gianluigi Tanda; Filippo Drago; Jean Lud Cadet; Steven R Goldberg; Sevil Yasar
Journal:  Learn Mem       Date:  2009-04-29       Impact factor: 2.460

5.  A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats.

Authors:  Choon-Gon Jang; Timothy Whitfield; Gery Schulteis; George F Koob; Sunmee Wee
Journal:  Psychopharmacology (Berl)       Date:  2012-09-25       Impact factor: 4.530

Review 6.  In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.

Authors:  Andrea Giuffrida; Lance R McMahon
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-06-10       Impact factor: 3.072

7.  Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.

Authors:  Leigh V Panlilio; Eric B Thorndike; Spyros P Nikas; Shakiru O Alapafuja; Tiziano Bandiera; Benjamin F Cravatt; Alexandros Makriyannis; Daniele Piomelli; Steven R Goldberg; Zuzana Justinova
Journal:  Psychopharmacology (Berl)       Date:  2015-11-12       Impact factor: 4.530

8.  Blocking TRPV1 in nucleus accumbens inhibits persistent morphine conditioned place preference expression in rats.

Authors:  Li-Jun Heng; Bo Huang; Heng Guo; Lian-Ting Ma; Wei-Xin Yuan; Jian Song; Peng Wang; Guo-Zheng Xu; Guo-Dong Gao
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

Review 9.  An update on PPAR activation by cannabinoids.

Authors:  Saoirse Elizabeth O'Sullivan
Journal:  Br J Pharmacol       Date:  2016-05-19       Impact factor: 8.739

10.  Pharmacological Blockade of PPARα Exacerbates Inflammatory Pain-Related Impairment of Spatial Memory in Rats.

Authors:  Jessica C Gaspar; Catherine Healy; Mehnaz I Ferdousi; Michelle Roche; David P Finn
Journal:  Biomedicines       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.